The 20 Best Hereditary Retinoblastoma Doctors Near Me in New York, US

David Abramson is an Oncologist in New York, New York. Dr. Abramson is rated as an Elite provider by MediFind in the treatment of Hereditary Retinoblastoma. His top areas of expertise are Retinoblastoma, Hereditary Retinoblastoma, Melanoma of the Eye, Vitrectomy, and Leg or Foot Amputation. Dr. Abramson is currently accepting new patients.

. Dr. O'reilly is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. Her top areas of expertise are Ringworm, Maturity Onset Diabetes of the Young, Familial Hypertension, and Hypertension.

Jasmine Francis is an Oncologist in New York, New York. Dr. Francis is rated as a Distinguished provider by MediFind in the treatment of Hereditary Retinoblastoma. Her top areas of expertise are Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Vitrectomy, and Liver Embolization. Dr. Francis is currently accepting new patients.

Dr. Paul T. Finger has collected or discovered the latest and most advanced medical technologies for the diagnosis and treatment of ocular tumors and eye cancer.With great respect for collaboration, he works closely with you, your referring doctor and his associated specialists to provide the most excellent care possible.The New York Eye Cancer Center was designed to be a responsive and caring environment, we strive to be your and your doctor's first choice for eye cancer care.Dr. Finger is the Director of Ocular Tumor Services at the Manhattan Eye, Ear and Throat Hospital and teaches residents from the New York University School of Medicine.A world-recognized expert in radiation and surgical techniques to conserve the eye and vision; Dr. Finger has pioneered the use of palladium-103 plaque radiation for choroidal melanoma, 3D and high-frequency ultrasound to image intraocular tumors, and created this world-renowned web site. Dr. Finger publishes in the major clinical journals and lectures frequently at local, national and international meetings. He graduated from Tulane Medical School, the Manhattan Eye, Ear and Throat Hospital, and then completed specialty training in treatment of ocular tumors and orbital diseases.Dr. Finger is certified by the American Board of Ophthalmology and is a Fellow of both the American College of Surgeons and the American Academy of Ophthalmology and sees patients from all over the world.Dr Finger was a principal investigator for The Collaborative Ocular Melanoma Study. He Chaired the Ophthalmic Oncology Task Force that wrote the 2014 consensus guidelines for plaque radiationt therapy of choroidal melanoma and retinoblastoma for The American Brachytherapy Society. Dr. Finger was the clinical director for the Plaque Radiation Therapy (Task Group 129) of the American Association for Physicists in Medicine (AAPM). Dr. Finger is Chair of the Ophthalmic Oncology Task Group of The American Joint Committee on Cancer (AJCC) - International Union Against Cancer (UICC). The AJCC-UICC has created a universal language (TNM-classification) commonly used around the world to describe eye cancer.Dr. Finger has a particular interest in melanoma of the choroid, ciliary body and iris. He has written extensively about new ways to detect and treat retinoblastoma, conjunctival melanoma, squamous carcinoma, metastatic cancer to the eye and orbital tumors.Dr. Finger has assembled a team to care for patients with eye tumors. By picking the best doctors from several institutions, his team includes the top radiation, medical and pediatric oncologists from several institutions in New York City.Dr. Finger has spent his career inventing and improving new methods of diagnosis and treatment for eye cancer:. Dr. Finger is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. His top areas of expertise are Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, Iridectomy, and Vitrectomy.

David Tegay is a Medical Genetics provider in Great Neck, New York. Dr. Tegay is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. His top areas of expertise are KBG Syndrome, Gaucher Disease, Gaucher Disease Type 2, and Gaucher Disease Type 3.

Brian Marr, MD heads the Ophthalmic Oncology Service at the Harkness Eye Institute. He has comprehensive experience in the diagnosis, treatment, and management of ocular tumors including intraocular tumor resection, laser, radiation, and chemotherapy procedures. He has helped devise thousands of complex treatments for tumors of the eye, eyelid, orbit, and conjunctiva for his adult, children, and infant patients. Currently, Dr. Marr is a collaborator on a Columbia University clinical trial for a first-of-its-kind, new class of drug treatment for uveal melanoma.Dr. Marr is a board-certified ophthalmologist whose work has centered around ophthalmic oncology since 2000. One of the very few ocular oncologists trained in all aspects of eye cancer, Dr. Marr's clinical experience in treating these diseases is among the most extensive in the United States. His interest and experience in ophthalmic oncology began during an eight-year tenure in the Ocular Oncology Service at the Wills Eye Hospital in Philadelphia. There, he gained extensive experience treating intraocular tumors, and tumors of the eyelid, orbit, and conjunctiva in children and adults. It was there that Dr. Marr developed and improved many surgical procedures used to cure cancers of the eye, successfully treated thousands of patients, and helped their families though their battle with eye cancer. Next, Dr. Marr moved on to Memorial Sloan Kettering Cancer Center, where he remain for nine years, starting in 2008.Dr. Marr has some of the greatest experience with intra-arterial chemotherapy for treating retinoblastoma in the country, if not the world, as well as all other forms of retinoblastoma treatment. He has been a key member of many multidisciplinary surgical teams, treating advanced skull base tumors and complex facial skin lesions. He has developed a strong belief and treatment philosophy that the best research be used to help his patients, rather than his best patients be used to help his research. The field of ophthalmic oncology encompasses many rare conditions and his experience helps his patients get the best care and results as quickly as possible. Dr. Marr lectures and consults across the US and abroad, and has authored numerous research articles in the field of ocular oncology. He is the principal investigator in a first-in-class drug study for treating primary uveal melanoma, in an international, multi-center trial. He also volunteers his medical expertise in underserviced parts of the world, such as Nigeria and Indonesia, and has helped train physicians in more than 20 countries. Dr. Marr’s efforts as a contributor to ongoing education in ocular oncology have been recognized by the American Academy of Ophthalmology, where he now serves as chief editor of the Academy’s Oncology and Pathology’s One network. Dr. Marr is rated as an Advanced provider by MediFind in the treatment of Hereditary Retinoblastoma. His top areas of expertise are Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, and Vitrectomy.

Paul Reznikov is a Radiologist in Syracuse, New York. Dr. Reznikov is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. His top areas of expertise are Thyroid Nodule, Melorheostosis with Osteopoikilosis, Melorheostosis, and Osteopenia.

Anita Price is a Pediatric Radiologist in New York, New York. Dr. Price is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. Her top areas of expertise are Pleurisy, Pleural Effusion, WT1-Related Wilms Tumor Syndromes, Pancreaticoduodenectomy, and Orchiectomy.

Robert Young is a Neuroradiologist in New York, New York. Dr. Young is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. His top areas of expertise are Posterior Fossa Tumor, Astrocytoma, Brain Tumor, and Metastatic Brain Tumor.

Ekaterina Semenova is an Ophthalmologist in New York, New York. Dr. Semenova is rated as an Advanced provider by MediFind in the treatment of Hereditary Retinoblastoma. Her top areas of expertise are Melanoma of the Eye, Retinoblastoma, Choroid Plexus Carcinoma, Iridectomy, and Corneal Transplant. Dr. Semenova is currently accepting new patients.

Manuela Orjuela-Grimm is a molecular epidemiologist and pediatric oncologist whose research focuses on vulnerability (including social) to environmental exposures, gene-nutrient/ environment interactions during windows of susceptibility such as pregnancy, early childhood, adolescence and the development of later genetic and epigenetic changes contributing to poorer health outcomes in childhood and adolescence. She leads EpiRbMx, a long-standing case control/ case series study examining exposure to methyl donors, folate pathway metabolism and risk for retinoblastoma in collaboration with a multidisciplinary team of investigators including the Hospital Infantil de Mexico, the Hospital de Pediatria at the Instituto Mexicano de Seguro Social (IMSS), the Instituto Nacional de Salud Publica (INSP), and the University of Toronto. In collaboration with INSP researchers, Dr. Orjuela is involved in multiple studies examining the intersection between food security, folate-related dietary intake, dietary diversity and environmental exposures in central Mexico, and in immigrants in New York.Interests: social contributors to dietary exposures, gene-nutrient interactions; one carbon donor metabolism; methylation; nutrient and environmental exposures during early life and later genetic and epigenetic effects; dietary assessment in Mexico, in populations on the move in Latin America; effects of acculturation and early life migration on nutrient/ environmental exposures in US Latinos. Dr. Orjuela is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. Her top areas of expertise are Retinoblastoma, Hereditary Retinoblastoma, Acute Lymphoblastic Leukemia (ALL), and Embryonal Tumor with Multilayered Rosettes.

Lauren Yeager, MD graduated Phi Beta Kappa from the Honors College at the University of Michigan with a degree in Biopsychology and Cognitive Science. She received her medical degree from Boston University School of Medicine and then completed an internal medicine internship at Mount Sinai Hospital in New York, New York. She completed a general ophthalmology residency at State University of New York (SUNY) Downstate Medical Center and then went on to complete a fellowship in pediatric ophthalmology and strabismus at Children’s National Medical Center in Washington, DC. Dr. Yeager specializes in pediatric and adult strabismus, as well as the treatment of all childhood eye conditions. She is fellowship trained to perform a wide variety of pediatric ophthalmic surgeries, including pediatric cataract surgery, anterior segment surgery, lacrimal system surgery, and eyelid surgery. Dr. Yeager is interested in international health care and has participated in multiple medical and surgical mission trips to the Dominican Republic. She has also presented at numerous national meetings, including the Association for Research in Vision and Ophthalmology, the Constenbader Society, and the American Society of Ophthalmic Plastic and Reconstructive Surgery. Dr. Yeager is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. Her top areas of expertise are Strabismus, Amblyopia, Epicanthal Folds, and Esotropia.

Christopher Barker is a Radiation Oncologist in New York, New York. Dr. Barker is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Squamous Cell Skin Carcinoma, Melanoma of the Eye, and Liver Embolization. Dr. Barker is currently accepting new patients.

Ira Dunkel is a Hematologist and an Oncologist in New York, New York. Dr. Dunkel is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. His top areas of expertise are Retinoblastoma, Diffuse Midline Glioma H3 K27M-Mutant, Brain Stem Cancer, and Glioma. Dr. Dunkel is currently accepting new patients.

Y Gobin is a Radiologist in New York, New York. Dr. Gobin is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. His top areas of expertise are Retinoblastoma, Brain Aneurysm, Arteriovenous Malformation, Hereditary Retinoblastoma, and Thrombectomy.

Kayleen Bailey is a Hematologist and an Oncologist in New York, New York. Dr. Bailey is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Sickle Cell Disease, Hereditary Spherocytosis, and Hodgkin Lymphoma.

Joseph Readling is an Oncologist in Binghamton, New York. Dr. Readling is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. His top areas of expertise are Atypical Hemolytic Uremic Syndrome (aHUS), Hemolytic-Uremic Syndrome, D-Plus Hemolytic Uremic Syndrome, and Paget Disease of the Breast.

Emily Tonorezos is an Internal Medicine provider in New York, New York. Dr. Tonorezos is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. Her top areas of expertise are Retinoblastoma, Anal Cancer, Acute Lymphoblastic Leukemia (ALL), Splenectomy, and Gallbladder Removal.

Nimesh Desai is a primary care provider, practicing in Internal Medicine in Massena, New York. Dr. Desai is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. His top areas of expertise are Hypothyroidism, Lung Metastases, Obesity in Children, and Male Pseudohermaphroditism with Gynecomastia.

Gennady Landa is an Ophthalmologist in New York, New York. Dr. Landa is rated as an Experienced provider by MediFind in the treatment of Hereditary Retinoblastoma. His top areas of expertise are Retinal Detachment, Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal.